Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 16 Sept 2024 for Mereo BioPharma Group plc, €37k.
Filing timeline
BuySaleChristine Ann Fox
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Christine Ann Fox: trading record in brief
This profile gathers the share dealings of Christine Ann Fox in Mereo BioPharma Group plc. We count 6 filings; the first trade dates from 21 June 2024 and the latest from 13 September 2024.
No open-market purchase appears, only 4 sales worth €248k. The rest of the record consists of 2 option exercises.
The latest filing, published on 16 September 2024, reports an open-market sale of €73k in Mereo BioPharma Group plc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christine Ann Fox
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
9,128 shares@ US$4.472745.1% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-106970:0
60,000 shares0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-106419:0
12,990 shares@ US$3.693954.9% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-078467:0
90,000 shares0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-077480:0
4 of 4 declarations
